PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 9 days 15 hours 55 minutes
Originators, Generics, and Biosimilars: How They Are Assessed
Originators, Generics, and Biosimilars: How They Are Assessed
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
State of the Science in CKD: New Treatment, New Outcomes
State of the Science in CKD: New Treatment, New Outcomes
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now
Taking the Sting Out of Hyperkalaemia: What Clinicians Can Do Now
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Conversations in Cardiology: Improving Recognition and Management of Hypertrophic Cardiomyopathy
Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment
Spotlight on Multifocal Motor Neuropathy: Strategies to Improve Diagnosis and Treatment
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
Innovation in Antibody Drug-Conjugate Engineering: Will It Pay Off?
PARPs in Practice in mCRPC: A Look at the Latest Data
PARPs in Practice in mCRPC: A Look at the Latest Data